Synthesis and Immunological Activity of a Branched Peptide Carrying the T-cell Epitope of gp43, the Major Exocellular Antigen of Paracoccidioides brasiliensis

Scandinavian Journal of Immunology

Volumn 59, Issue 1, 2004, Pages 58-65

  Taborda, C P ^a   Nakaie, C R ^b   Cilli, E M ^b   Rodrigues, E G ^b   Silva, L S ^b   Franco, M F ^b   Travassos, L R ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; FREUND ADJUVANT; FUNGUS ANTIGEN; GLYCOPROTEIN; GLYCOPROTEIN GP 43; LEUKOCYTE ANTIGEN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; FUNGAL VIRULENCE; FUNGUS ISOLATION; HAPLOTYPE; HELPER CELL; HUMAN; IMMUNIZATION; IMMUNOLOGY; IMMUNOREACTIVITY; LYMPH NODE CELL; MALE; MOLECULAR WEIGHT; MOUSE; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, FUNGAL; EPITOPES, T-LYMPHOCYTE; FEMALE; FUNGAL PROTEINS; FUNGAL VACCINES; GLYCOPROTEINS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MOLECULAR SEQUENCE DATA; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; PEPTIDES;

EID: 0442276187     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01359.x     Document Type: Article

References (43)

1. Mendes R. The Gamut of Clinical Manifestation. In: Franco M, Lacaz CS, Restrepo A, del Negro G, eds. Paracoccidioidomycosis. Boca Raton, Florida: CRC press, 1994, 233-58.
2. McEwen JG, Garcia AM, Ortiz BL, Botero S, Restrepo A. In search of the natural habitat of Paracoccidioides brasiliensis. Arch Med Res 1995;26:305-6.
3. Wanke B, Londero AT. Epidemiology and Paracoccidioidomycosis Infection. In: Franco M, Lacaz CS, Restrepo A, del Negro G, eds. Paracoccidioidomycosis. Boca Raton, Florida: CRC press, 1994, 109-17.
4. Franco M. Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol 1987;25:5-18.
5. Puccia R, Schenkman S, Gorin PA, Travassos LR. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun 1986;53:199-206.
6. Stambuk BU, Puccia R, de Almeida ML, Travassos LR, Schenkman S. Secretion of the 43 kDa glycoprotein antigen by Paracoccidioides brasiliensis. J Med Vet Mycol 1988;26:367-73.
7. Puccia R, Travassos LR. 43-kilodalton glycoprotein from Paracoccidioides brasiliensis: immunochemical reactions with sera from patients with paracoccidioidomycosis, histoplasmosis, or Jorge Lobo's disease. J Clin Microbiol 1991;29:1610-5.
8. De Camargo Z, Unterkircher C, Campoy SP, Travassos LR. Production of Paracoccidioides brasiliensis exoantigens for immunodiffusion tests. J Clin Microbiol 1988;26:2147-51.
9. Taborda CP, Camargo ZP. Diagnosis of paracoccidioidomycosis by passive haemagglutination assay of antibody using a purified and specific antigen-gp43. J Med Vet Mycol 1993;31:155-60.
10. Rodrigues EG, Travassos LR. Nature of the reactive epitopes in Paracoccidioides brasiliensis polysaccharide antigen. J Med Vet Mycol 1994;32:77-81.
11. Saraiva EC, Altemani A, Franco MF, Unterkircher CS, Camargo ZP. Paracoccidioides brasiliensis-gp43 used as paracoccidioidin. J Med Vet Mycol 1996;34:155-61.
12. Taborda CP, Juliano MA, Puccia R, Franco M, Travassos LR. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun 1998;66:786-93.
13. Pinto AR, Puccia R, Diniz SN, Franco MF, Travassos LR. DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis. Vaccine 2000;18:3050-8.
14. Schott ME, Wells DT, Schlom J, Abrams SI. Comparison of linear and branched peptide forms (MAPs) in the induction of T helper responses to point-mutated ras immunogens. Cell Immunol 1996;174:199-209.
15. Christodoulides M, Rattue E, Heckels JE. Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin. Vaccine 1999;18:131-9.
16. Olszewska W, Obeid OE, Steward MW. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 2000;272:98-105.
17. Joshi MB, Gam AA, Boykins RA et al. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates. Infect Immun 2001;69:4884-90.
18. Levi M, Ruden U, Birx D et al. Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1. J Acquir Immune Defic Syndr 1993;6:855-64.
19. IUPAC-IUB Commission on Biochemical Nomenclature. Symbols for amino-acid derivatives and peptides. Recommendations (1971). J Biol Chem 1972;247:977-83.
20. Hirata IY, Cezari MHS, Nakaie CR et al. Internally quenched luorogenic protease substrates: solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyldinitrophenyl groups as donor-acceptor pairs. Lett Pept Sci 1994;1:299-308.
21. Atherton B, Sheppard RC. Solid Phase Peptide Synthesis: A Practical Approach. Oxford: Oxford University Press, 1989.
22. Barany G, Merrifield RB. Solid Phase Peptide Synthesis. New York: Academic Press, 1980.
23. Knorr R, Trzeciak A, Bannwarth W, Gillessen D. New coupling reagents in peptide chemistry. Tetrahedron 1989;30:1927-30.
24. Cilli EM, Oliveira E, Marchetto R, Nakaie CR. Correlation between solvation of peptide-resins and solvent properties (1). J Org Chem 1996;61:8992-9000.
25. Marchetto R, Etchegaray A, Nakaie CR. Kinetics of synthesis and swelling of highly substituted benzhydrylamine-resins: implications for peptide synthesis and perspectives for use as anion exchanger resin. J Braz Chem Soc 1992;3:30-7.
26. Almeida IC, Covas DT, Soussumi LM, Travassos LR. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 1997;37:850-7.
27. Almeida IC, Rodrigues EG, Travassos LR. Chemiluminescent immunoassays: discrimination between the reactivities of natural and human patient antibodies with antigens from eukaryotic pathogens, Trypanosoma cruzi and Paracoccidioides brasiliensis. J Clin Lab Anal 1994;8:424-31.
28. Posnett DN, McGrath H, Tam JP. A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain. J Biol Chem 1988;263:1719-25.
29. Tam JP. Recent advances in multiple antigen peptides. J Immunol Methods 1996;196:17-32.
30. Malavolta L, Oliveira E, Cilli EM, Jubilut GN, Nakaie CR. Solvation of polymers as model for solvent effect investigation: proposition of a novel polarity scale. Tetrahedron 2002;58:4383-94.
31. Argiro L, Henri S, Dessein H, Koutiba B, Dessein AJ, Bourgois A. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum. Vaccine 2000;18:2033-8.
32. Avila SL, Goldberg AC, Arruk VG et al. Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria. Parasite Immunol 2001;23:103-8.
33. Kublin JG, Lowitt MH, Hamilton RG et al. Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. Vaccine 2002;20:1853-61.
34. Manki A, Ono T, Uenaka A, Seino Y, Nakayama E. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia. Cancer Res 1998;58:1960-4.
35. Drijfhout JW, Bloemhoff W. A new synthetic functionalized antigen carrier. Int J Pept Protein Res 1991;37:27-32.
36. Nakaie CR, Marchetto R, Schreier S, Paiva ACM. High loading effect in solid phase peptide synthesis: swelling and ESR approaches. In: Rivier JE, Marshall GR, eds. Peptides - Chemistry, Structure and Biology. Leiden: ESCOM, 1990:1022-3.
37. Oliveira E, Miranda A, Albericio F et al. Comparative evaluation of the synthesis and purification of transmembrane peptide fragments. Rat bradykinin receptor fragment 64-97 as model. J Pept Res 1997;49:300-7.
38. Cilli EM, Marchetto R, Schreier S, Nakaie CR. Correlation between the mobility of spin labeled peptide chains and resin solvation: an approach to optimize the synthesis of aggregating sequences. J Org Chem 1999;64:9118-23.
39. Cilli EM, Marchetto R, Schreier S, Nakaie CR. Use of spin label EPR spectra to monitor peptide chain aggregation inside resin beads. Tetrahedron 1997;38:517-20.
40. Marchetto R, Schreier S, Nakaie CR. A novel spin-labeled aminoacid derivative for use in peptide synthesis: (9-fluorenylmethyloxycarbonyl) 2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid. J Am Chem Soc 1993;115:1142-3.
41. Grillot D, Valmori D, Lambert PH, Corradin G, Del Giudice G. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes. Infect Immun 1993;61:3064-7.
42. Huang W, Nardelli B, Tam JP. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine. Mol Immunol 1994;31:1191-9.
43. Tam JP, Spetzler JC. Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks. Biomed Pept Proteins Nucleic Acids 1995;1:123-32.